← Search

Omics · study · 2026

Synergistic activity of simvastatin and irinotecan chemotherapy against glioblastoma converges on TGF-β

Listed in NCBI GEO

Glioblastoma (GBM) is the most common and aggressive primary brain tumor, with a dismal prognosis and inevitable recurrence after standard-of-care therapy.

Description

This warrants the need for rapidly translatable, more effective GBM treatments. We have therefore investigated the therapeutic potential of a novel combination of the repurposed drug simvastatin with irinotecan chemotherapy (CPT-11).

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
Cancer 65%
Provenance · 1 source records, 8 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE29772815 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (65%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title